SEC Form 4 · accession 0001437749-18-000187
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Dec 31, 2017
Accepted (ET)
Jan 3, 2018 · 6:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 31, 2017 | A | 71,273 | $0.39 | A | 22,210,285 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares received in exchange for a reduction in $27,796.40 owed by Registrant to Reporting Person for salary and unreimbursed business expenses.
- F2Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.